2m 2m 2m 2m 2m 2m 2m
Gelteq (GELS)
NASDAQ
$0.53-$0.01 (-2.74%)
Price as of Jul 14, 2026 8:38 AM EDT- N/AMarket Cap
- -69.33%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Gelteq (GELS)
$0.53-$0.01 (-2.74%)
GELS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | +$0.01 (+2.82%) | ||
Open | $0.51 | ||
High | $0.55 | ||
Low | $0.50 | ||
Previous Close | $0.53 | ||
Volume | 29,593 | ||
30-Day Average Volume | 3,449,700 | ||
1-Week Change | -9.69% | ||
1-Month Change | -45.47% | ||
1-Year Change | -69.33% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.4M | ||
Total Assets | $21.5M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||